Euro-Med Laboratories Phil., Inc. (EURO) Stock Price
Data as of: 21-Jan-2025 Tue 3:30 PM / (Last Trading)
₱0.790
1.28%
(
$0.0135
in USD
)
Trading Data
Open Price
₱0.790
Day Low / High
₱0.780 - ₱0.790
52W Low / High
₱0.710 - ₱0.920
Trade Amount
₱790
Trade Volume
1,000
Valuation Metrics
Market Cap
₱3.25 Billion
P/E Ratio
39.50
Earnings Per Share
₱0.0200
Book Value
₱1.45
Dividend Yield
-
The stock price of EURO today is ₱0.790, based on the most recent trading session. EURO share price increased by 1.28% (see other notable gainers), with a trading volume of 1,000 shares.
Price Data by Timeframe
The table below provides a snapshot of the stock's performance over various timeframes.
Period | % Change | Average Price | Highest Price | Lowest Price | Average Volume | Average Trade |
---|---|---|---|---|---|---|
7 Days | 1.28% | ₱0.770 | ₱0.790 | ₱0.720 | 23,400 shares | ₱17,908 |
1 Month | -11.24% | ₱0.820 | ₱0.890 | ₱0.720 | 30,882 shares | ₱25,262 |
3 Months | 0% | ₱0.840 | ₱0.920 | ₱0.720 | 64,793 shares | ₱56,861 |
6 Months | 1.28% | ₱0.790 | ₱0.920 | ₱0.710 | 48,908 shares | ₱40,420 |
YTD | -3.66% | ₱0.810 | ₱0.880 | ₱0.720 | 29,429 shares | ₱23,721 |
1 Year | 1.28% | ₱0.770 | ₱0.920 | ₱0.710 | 28,946 shares | ₱23,610 |
Related Stocks:
EURO Stock Information
Sector
Industrial
Subsector
Chemicals
Outstanding Shares
4,112,140,540
Share Type
Common
Listing Date
Jul 02, 1998
ISIN
PHY2352T1098
Board Lot
1000
Company Profile
Euro-Med Laboratories Philippines, Inc. (EURO) was incorporated and registered with the Securities and Exchange Commission on January 29, 1988. Upon receipt of the licenses and product registration approvals from the Food and Drug Administration Philippines, EURO began commercial production in 1991.EURO is engaged in the manufacture of pharmaceutical products such as large and small volume parenteral and other solutions. The Company also manufactures sterile water for injection, and other solutions such as ophthalmic, inhalation, irrigation and dialysis. EURO is likewise engaged in the toll manufacturing of pharmaceutical products in liquid form.The Company's subsidiaries are Hemotek Renal Center, Inc., which is engaged as a dialysis center; and CafeFrance Corp., which is engaged to operate restaurants, bakeries, food services, catering, food production, and other related services.Source: SEC Form 17-A (2023)